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Abstract: Valproic acid (2-n-propylpentanoic acid, VPA) is a widely used antiepileptic and anticonvulsant drug. Previous studies 
have reported that VPA effects osteogenesis in vivo and in vitro, yet it remains unclear whether VPA promotes cell differentiation of 
osteoblasts derived from mesenchymal cells. The purpose of this study was to clarify the effect of VPA on undifferentiated pluripotent 
mesenchymal cell proliferation and differentiation into osteoblasts while analyzing the impact of the absence or presence of extracel-
lular matrices (ECMs). Mouse mesenchymal cells were cultured on non-coated plastic, type I collagen-coated, and fibronectin-coated 
plates in the absence or presence of VPA. A cell proliferation assay was performed in which modified formazan dye content was ana-
lyzed and proliferation nuclear antigen (PCNA)-positive cells were counted at various concentrations of VPA. A high concentration of 
VPA did not clearly alter cell morphology, but large numbers of stress fibers were observed in these cells and the cell proliferation ratio 
was decreased with positive PCNA counts. In the presence of matrices, the cell proliferation ratio decreased at low VPA concentrations 
compared with the ratio obtained in the absence of these ECMs. On the other hand, VPA promoted osteoblastic differentiation in the 
presence of type I collagen. These findings indicate that for undifferentiated mesenchymal cells, VPA promotes a decrease in the cell 
proliferation rate in the presence of ECMs and promotes osteoblastic differentiation, both of which could provide insight into additional 
mechanisms of osteoblastic cell differentiation caused by VPA.
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Introduction
Valproic acid (2-n-propylpentanoic acid, VPA) is an 
effective and widely used antiepileptic and anticon-
vulsant drug, and recent studies have reported that 
VPA influences osteogenesis in vivo and in vitro.1–4 
It has been reported that VPA has no effect on osteo-
genesis  identified  with  calcification  nodule  forma-
tion by a preosteoblast cell line derived from mouse 
calvaria, MC3T3-E1 cells.5 On the other hand, VPA 
promotes the cell proliferation of a pre-osteoblast cell 
line and the Runx2 gene, which plays a critical role in 
osteoblast differentiation, with transcriptional activ-
ity promoted in MC3T3-E1.4 These findings indicate 
that skeletal malformation caused by VPA may result 
in response to cell proliferation and/or cellular dif-
ferentiation of preosteoblasts, and may not result in 
calcification by mature osteoblasts.
Bone  is  composed  of  not  only  osteoblasts  and 
osteocytes  but  also  chondrocytes  and  adipocytes, 
which are organized and integrated so as to main-
tain bone homeostasis. These various types of cells 
are all derived from mesenchymal stem cells. Mouse 
embryonic mesenchymal cells C3H10T1/2 are pluri-
potent cells which can be differentiated into osteo-
blasts,  chondrocytes,  adipocytes,  and  myoblasts  in 
vitro.6–8 This cell line is widely used as a model of 
mesenchymal  cell  differentiation  as  it  represents  a 
homogeneous population of pluripotent cells that do 
not spontaneously differentiate under normal culture 
conditions.
Extracellular matrices (ECMs), a complex mix-
ture  of  matrix  molecules,  including  collagen  and 
fibronectin,  provide  scaffolds  for  cellular  support 
that are present in all tissues, organs, and cell-matrix 
adhesion signals, and regulate biological processes 
such as cell survival and proliferation.9 Both type I 
collagen and fibronectin play a critical role in osteo-
genic cell proliferation and cell differentiation both 
in vivo and in vitro;10–13 however, it remains unclear 
what the effect of VPA is on undifferentiated mesen-
chymal cell proliferation and cell differentiation in 
the presence of ECMs, especially to fibronectin and 
type I collagen.
The aim of this study is to investigate the effect of 
VPA on the cell differentiation and proliferation of 
mesenchymal cells which can differentiate into cells 
composed of mesenchymal tissues, including those 
found in bone. We observed a normal mesenchymal 
cell shape but large number of stress fibers in cells in 
the presence of a high concentration of VPA, and these 
mesenchymal cells were also able to proliferate on a 
non-coated plastic plate. However, mesenchymal cell 
proliferation was inhibited when cells were cultured 
on ECM-coated plates, even in low concentrations of 
VPA, and VPA promoted the expression of osteoblas-
tic cell marker genes. In an   osteogenesis-inductive 
medium, VPA promoted osteogenesis on both non-
coated  plastic  and  collagen-coated  plates.  These 
observations may reflect the in vivo cell conditions 
and provide further insight into the osteoblastic cell 
differentiation mechanism caused by VPA.
Materials and Methods
cell culture
A  mouse  embryonic  mesenchymal  cell  line, 
C3H10T1/2 Clone 8 cells, was obtained from Riken 
Bioresource  Center  Cell  Bank  (Tsukuba,  Japan). 
Cells were cultured in basal medium Eagle (BME) 
containing 10% fetal bovine serum (FBS, Equitech-
Bio Inc., Tokyo, Japan) and antibiotics (100 U/ml 
of penicillin-G and 100 mg/ml of streptomycin) at 
37 °C in a humidified atmosphere of 5% CO2 in air. 
The  medium  was  changed  twice  a  week.  Before 
reaching  confluence,  the  cells  were  passaged  for 
use  in  experiments.  VPA  (valproic  acid  sodium, 
M.W. = 166.19) was purchased from Wako (Tokyo, 
Japan), diluted in sterilized phosphate-buffered saline 
at 100 mg/ml, and added to C3H10T1/2 at various 
final concentrations for indicated periods of time.
cell counting
The  proportional  values  of  cells  were  counted 
using  Cell-counting  kit-8  (Dojindo  Laboratories, 
Kumamoto, Japan), which measures a highly water-
soluble  formazan  dye  produced  from  tetrazolium 
salts. Cells were seeded at 1.0 × 103 cells per well on 
a 96-well plate and the medium was changed, along 
with various concentrations of VPA, after cell attach-
ment to non-coated plastic, type I collagen-coated and 
fibronectin-coated 96-well plates (Becton-Dickinson, 
Tokyo, Japan). After 48- and 96-hour cell cultures, 
cells were incubated with the counting reagent for one 
hour, according to the manufacturer’s instructions, and 
the relative cell number was determined by measuring 
light absorbance at a wavelength of 450 nm of the for-
mazan dye product in the cultures. To determine the The effect of VPA on mesenchymal cell in ecM
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number of viable cells cultured in VPA, a trypan blue 
dye exclusion test was used. Mesenchymal cells were 
cultured at various concentration of VPA for 48 hours 
and 96 hours on the non-coated plastic, fibronectin- 
and type I collagen-coated 24-well plate. After cell 
culture, 0.4% solution of trypan blue was added to 
equal volumes of the harvested cell suspensions. The 
ratio of stained to unstained cells was estimated using 
a hemocytometer.
Proliferating cell nuclear antigen (PcnA) 
staining and cytoskeleton staining
Before  the  experiment,  C3H10T1/2  cells  were 
trypsinized from a standard tissue culture plate and 
seeded  in  a  Lab-Tek  chamber  slide  (Nalge  Nunc, 
Tokyo, Japan), to which they adhered during incu-
bation  overnight  in  a  standard  medium. After  cell 
adherence,  they  were  cultured  for  an  additional 
48 hours after changing the medium to include VPA 
concentrations of 10, 100 and 1000 µg/ml. After an 
additional 48-hour culture, cells were fixed with 4% 
paraformaldehyde  in  0.01  M  phosphate-buffered 
saline (PBS) and proliferating cell nuclear antigen 
(PCNA) and cyctoskeleton staining was performed. 
PCNA was detected by a ZYMED PCNA staining kit 
  (Invitrogen, Tokyo, Japan) according to the manu-
facturer’s  instructions.  Briefly,  after  fixation,  cells 
were incubated with blocking solution and incubated 
with biotinylated mouse anti-PCNA for 60 minutes 
at room temperature. The color was developed using 
diaminobenzidine (DAB)  as the substrate included 
in the kit. Negative cells were counterstained with 
  hematoxylin. The  PCNA-positive  cell  counts  were 
expressed  as  a  ratio  of  total  cells,  including  both 
positive and negative PCNA within a defined area of 
500 µm² taken from five different areas in each test 
group.  For  F-actin  cytoskeleton  observation,  cells 
were incubated with Molecular Probes Alexa Fluor 
488-FITC (Invitrogen) and DNA stained with 1, 4, 
6-diamidino-2-phenylindole (DAPI).
Semi-quantitative reverse transcription 
polymerase chain reaction (rT-Pcr)
Mouse  mesenchymal  cells  were  cultured  on  a 
non-coated  plastic  or  type  I  collagen-coated  plate 
in  the  absence  or  presence  of  1  µg/ml  VPA  in 
  alpha-modified Eagle’s minimum essential medium 
(α-MEM,    Invitrogen)  containing  10%  FBS  and 
  antibiotics,   supplemented with 50 ug/ml ascorbic acid 
2-phospahte (Sigma, St. Louis, MO, USA) and 0.1 µM 
  dexamethasone. After a one-week culture, total RNA 
was isolated from cultured cells using an RNeasy Mini 
kit (Qiagen, Inc., Valencia, CA, USA), according to 
the  manufacturer’s  instructions.    One-step  RT-PCR 
was performed using a Superscript one-step RT-PCR 
with  a  Platinum  Taq  kit  (Invitrogen    Corporation, 
Carlsbad,  CA,  USA)  according  to  the  manufac-
turer’s  instructions,  and  a  Programmable  Thermal 
Controller PTC-100 (MJ Research, Watertown, MA, 
USA). To quantify the gene expression of collagen 
type I alpha 2 (collagen 1α2) and   non-collagenous 
bone  proteins  (osteopontin,  osteocalcin  and  bone 
sialoprotein (BSP)), semiquantitative RT-PCR, rela-
tive  to    glyceraldehyde-3-phosphate  dehydrogenase 
(GAPDH), was performed. Amplimers designed for 
these  four  molecules  were  previously  reported.14,15 
The PCR products were subjected to electrophoresis, 
and digital images were obtained and analyzed using 
IMAGE J (NIH image) software. Three populations 
of each cell type were studied.
Statistical analyses
All data are expressed as the mean ± standard   deviation 
(SD). Statistical significance was determined using 
one-way analysis of variance (ANOVA) followed by 
post-hoc t-test. Differences were considered signifi-
cant at a P value , 0.05.
Results
cell morphology
To examine the morphometric alteration of mesenchy-
mal cells and their cytoskeleton in the presence of VPA, 
we observed the F-actin-stained cytoskeleton content 
at various concentrations of VPA after a 48-hour cul-
ture period. Both in the absence and presence of VPA, 
mesenchymal cells showed a flattened and extended 
shape (Fig. 1). This cell shape was not clearly altered 
even at a high concentration of VPA, but a high F-actin 
stained cytoskeleton content was observed in the cells 
(Fig. 1D). This data suggests that VPA was able to 
maintain normal cell shape but also synthesized a large 
number of stress fibers in cells at high concentrations.
cell proliferation activity
To analyze mesenchymal cell proliferation activity 
when cells were cultured in VPA, we cultured cells hatakeyama et al
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at various concentrations, from 10 to 1000 µg/ml, 
because therapeutic levels appear to range from 50 
to 100 µg/ml in human serum, and also because we 
had  already  reported  that  a  VPA  concentration  of 
1000  µg/ml  affects  bone  resorption  in  rat  calvaria 
organ culture.16 The C3H10T1/2 mouse mesenchy-
mal cell line was cultured in the absence (0 µg/ml) or 
presence of various concentrations of VPA (10, 100, 
1000 µg/ml) for 48 hours on a non-coated plastic cell 
culture plate (Fig. 2A–D). After the cell culture period, 
cell  proliferation  activity  was  detected  by  PCNA 
  staining.  PCNA-negative  cells  were  counterstained 
by hematoxylin. At all VPA concentrations from 10 to 
1000 µg/ml, cells were attached to a non-coated plas-
tic cell culture plate and   PCNA-positive cells were 
observed  at  all  VPA  concentrations  (Fig.  2A–D). 
When PCNA-positive cell counts were obtained from 
five  randomly  chosen  areas  following  the  48-hour 
culture, the cell number decreased significantly only 
at a VPA concentration of 1000 µg/ml and there was 
no difference noted at other concentrations (Fig. 2E). 
These data indicate that VPA had no effect on mesen-
chymal cell proliferation when cells were cultured on 
a non-coated plastic plate.
AB
CD
0 µg/ml 10 µg/ml
100 µg/ml 1000 µg/ml
Figure  1.  VPA  does  not  alter  mesenchymal  cell  shape  even  in  high 
  concentrations.  Mesenchymal  cells  were  cultured  in  the  absence 
(0 µg/ml, A) or presence of VPA at various concentration (10 µg/ml, B., 
100 µg/ml, c., and 1000 µg/ml D) for 48 hours. cells were stained with 
F-actin (green) and nuclear counterstained with DAPI (blue). Both in the 
absence or presence of high concentrations of VPA, mesenchymal cells 
maintained a flattened and extended shape. 
note: The bar in D represents 50 µm.
Figure 2. Proliferation of pluripotent mesenchymal cells is inhibited by 
VPA at a high concentration. c3h10T1/2, a mouse mesenchymal cell 
line, was cultured in the absence (0 µg/ml, A) or presence of VPA at 
various concentration (10 µg/ml, B., 100 µg/ml, c., and 1000 µg/ml, D) 
for 48 hours. cell proliferation activity was detected by PcnA staining fol-
lowing cell culture. (A–D) PcnA-positive cells (brown) were present even 
at 1000 µg/ml. Negative cells were counterstained by hematoxylin (blue).   
e) Both PcnA-positive cell counts and total cell counts were obtained 
from five randomly chosen areas following the 48-hour culture period. 
The  bar  graph  expresses  the  relative  ratios  of  their  average    values. 
PCNA-positive cell numbers decreased significantly only at a VPA con-
centration of 1000 µg/ml when compared with the numbers obtained 
from the absence of VPA. 
notes: *P , 0.05 when compared to 0 µg/ml. The bar in D represents 
200 µm.
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effect of ecMs on cell number
For  quantitative  examination  of  the  VPA  effect  on 
cell  proliferation  in  the  presence  of  ECMs,  we  per-
formed a mesenchymal cell proliferation assay using 
fibronectin-  and  type  I  collagen-coated  cell  culture The effect of VPA on mesenchymal cell in ecM
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plates and   compared the results to an assay performed 
on the cells seeded on a non-coated plastic plate. Cell 
number on both the non-coated plastic plate and the 
ECM  plates  were  estimated  indirectly  using  highly 
water-soluble formazan dye as described in the Mate-
rials and Methods section. On the non-coated plastic 
plate (Fig. 3A), the cell counts at all doses of VPA, from 
1 to 1000 µg/ml, were significantly higher following 
the 96-hour culture than those following the 48-hour 
culture (n = 8, P , 0.01). Following both the 48- and 
96-hour culture periods, there were no significant cell 
number differences among the VPA doses, except for at 
the 1000 µg/ml concentration on the non-coated plas-
tic plate (Fig. 3A). These results indicated that only 
VPA  at  a  concentration  of  1000  µg/ml  reduced  the 
  mesenchymal cell proliferation level on the   non-coated 
plastic plate; however in the fibronectin- and type I col-
lagen-coated plate culture, the concentration of VPA at 
all concentrations, from 1 to 1000 µg/ml,   lowered the 
mesenchymal cell proliferation level when   compared 
to the 0 µg/ml concentration on   fibronectin- and   
type  I  collagen  -coated  plates  at  each  time  period 
(Fig. 3B and C). In the absence of VPA, mesenchy-
mal cell counts on the ECM plates were significantly 
higher than those on non-coated plastic plate following 
48-hour culture periods (Fig. 3A, B and C). When we 
took trypan blue positive cell counts in a cell suspen-
sion following the 48-hour and 96-hour culture, ratios 
of viable cells in non-coated plastic plate were no sig-
nificant differences found among the VPA concentra-
tions (Fig. 3D, Normal). On the ECM plates, ratios of 
viable cells at the 10 µg/ml were no significant differ-
ences comparing with 0 mg/ml following the 48-hour 
and 96-hour culture (Fig. 3D). These results indicated 
that VPA could reduce mesenchymal cell proliferation 
level at a relatively high concentration in the absence of 
ECMs; however, this reducibility effect is enhanced at 
relatively low concentrations in the presence of ECMs.
cell differentiation
Since a previous report indicated that VPA promoted 
osteoblastic cell differentiation from a   pre-osteoblastic 
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Figure 3. VPA reduced mesenchymal cell proliferation level in the presence of ecMs. Mesenchymal cells were cultured in the absence (normal, A) or 
presence (Fibronectin (B) and Type I collagen (c)) of extracellular matrices for 48 and 96 hours. Relative cell number was indicated by light absorbance at 
a wavelength of 450 nm of a formazan dye product in the culture. VPA, at relatively low concentrations, had no obvious inhibitory effect on mesenchymal 
cell proliferation when cultured in the absence of ecM (A); however, in the presence of ecM, VPA reduced mesenchymal cell proliferation level in a dose-
dependent manner (B, c). D) The ratios of viable cells on the ECM plates (Fibronectin (FBN), Type I Collagen (Col1)) were not decreased significantly at 
10 µg/ml following 48 hr- and 96 hr-culture period. n = 8 in each experiment group. 
notes: *P , 0.05; **P , 0.01 compared to 0 µg/ml for each time period.hatakeyama et al
6  Drug Target Insights 2011:5
cell line,4 we tested whether VPA promotes the expres-
sion of osteoblastic marker genes during sequential cell 
differentiation from mesenchymal cells to osteoblasts 
both  in  the  absence  or  presence  of  an  extracellular 
matrix, when cultured on non-coated plastic or type I 
collagen-coated plates. In the absence of VPA, the gene 
expressions of collagenous and of non-  collagenous bone 
matrices (ie, collagen 1α2, osteopontin and osteocalcin, 
which are osteoblastic marker genes) were detected in 
the mesenchymal cells cultured on a non-coated plastic 
plate with an inductive medium of osteoblastic cell dif-
ferentiation after a one-week culture (Fig. 4A, B, C, D; 
Normal). The expression levels of these marker genes 
were significantly promoted in the presence of 1 µg/ml 
VPA, except in the case of BSP. Similar to the results 
in the cell culture on the non-coated plastic plate, VPA 
significantly promoted the expression level of all genes, 
except for that of BSP, when compared with the absence 
of VPA in the cell culture on the collagen-coated plate 
(Fig. 4A, B, C, D; Collagen). Furthermore the increase 
in these gene expression levels was higher than that of 
the non-coated plastic plate both in the absence or pres-
ence of VPA. These results indicate that VPA promoted 
osteoblastic  cell  differentiation  from  mesenchymal 
cells cultured on the non-coated plastic plate and the 
co-presence of an extracellular matrix promoted osteo-
blastic differentiation. 
Discussion
VPA is an effective and widely used antiepileptic and 
anticonvulsant drug which influences osteogenesis in 
vivo and in vitro.1–3 In terms of osteogenesis, osteo-
blasts play a critical role in cooperating with various 
types of cells, which are all derived from mesenchy-
mal stem cells. The murine embryonic mesenchymal 
cell line, C3H10T1/2, is a pluripotent cell line which 
can be differentiated into osteoblasts, chondrocytes, 
adipocytes,  and  myoblasts  in  vitro  and  is  used  in 
numerous studies as a model for mesenchymal cell 
differentiation.6–8  ECMs  secreted  by  mesenchymal 
cells, including osteoblasts, also play a critical role in 
osteogenesis, and two ECM components, type I col-
lagen and fibronectin, are known to effect osteogenic 
cell proliferation and differentiation both in vivo and 
in vitro.10–13 In this study, we attempted to examine 
the effect of VPA in mesenchymal cell proliferation 
and cell differentiation in vitro in both the presence 
and absence of ECMs.
First we observed that normal cell shape was main-
tained, but a large number of stress fibers were formed 
in high concentrations of VPA after a 48-hour culture. 
Previous studies have reported that high concentra-
tions of VPA induced morphological changes in mouse 
osteoblast cell line MC3T3-E1 cells4 and mouse fibro-
blast cell line L929.17 Microarray analysis of somatic 
tissue of mouse embryos with applied VPA revealed 
that gene expression in the microtubule cytoskeleton 
and actin filament may be associated with axis skeletal 
malformations2 and increasing levels of F-actin were 
also observed in mouse fibroblasts.17 Our observations 
on the morphology of undifferentiated mesenchymal 
cells cultured in a VPA-containing medium is consis-
tent with these reports and suggests that VPA could 
rearrange the cytoskeleton of various types of cells.
In  the  cell  proliferation  on  a  non-coated  plastic 
plate, our results showed that mesenchymal cells were 
positive for PCNA at all VPA concentrations, from 1 
to 1000 µg/ml, after 48 hours and we detected no sig-
nificant differences between the control (0 µg/ml) and 
100  µg/ml  populations  cultured  for  48  hours  when 
PCNA-positive cell counts were obtained from a ran-
domly chosen area and also when the estimated cell 
number was determined from an assay utilizing water-
soluble formazan dye. Previous studies were performed 
at 0.1 µM to 3 mM VPA concentrations (corresponding 
to 0.08 to 480 µg/ml values) for cell viability and pro-
liferation assays in osteoblasts and neural crest cells.4,18 
In a mouse osteoblast cell line, MC3T3-E1, VPA pro-
moted cell proliferation at low concentrations of 0.1 to 
50 µM (corresponding to 0.08 to 4 µg/ml values) and 
decreased the cell proliferation rate at a high concen-
tration of 1 mM.4 On the other hand, neural crest cells 
could proliferate at 1.5 mM (240 µg/ml) concentrations 
of VPA and this was not significantly different to the 
control results.18 Taken together, our data suggested that 
the effect of VPA on cell proliferation is dependent on 
the maturation level of the cells, namely that immature 
cells have resistance to high concentrations of VPA.
In  the  present  study,  VPA  had  inhibitory  effect 
on the mesenchymal cell proliferation with culture 
on an ECM coat of fibronectin and type I collagen. 
Fibronectin and type I collagen are major components 
of ECMs and well known to promote mesenchymal 
cell proliferation.10–19 Consist with these reports, our 
data showed that fibronectin or type I alone had the 
effect of increasing cell proliferation in the absence The effect of VPA on mesenchymal cell in ecM
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Figure 4. VPA promoted osteoblastic cell differentiation both in the absence or presence of ecM. Mesenchymal cells were cultured in the absence 
  (control) or presence of VPA (VPA) on a non-coated plastic plate (normal) or type I collagen-coated plate (collagen) for each of the conditions for one 
week. The expression level of osteoblastic marker genes, Collagen type 1α2 (col 1α2), osteopontin (OPn), bone sialoprotein (BSP) and osteocalcin (Oc) 
were assayed by semi-quantitative rT-Pcr and each marker gene was normalized against gAPDh. On both non-coated plastic (normal) and collagen-
coated (Collagen) plates, VPA promoted the expression level of each marker gene significantly compared to the Control results (A, B, D), except in the 
case of BSP (c). When comparing Normal and Collagen conditions, VPA significantly increased marker gene levels cultured in the latter (A, B, D), except 
in the case of BSP (c). n = 3 in each experiment group. 
notes: *P , 0.05; **P , 0.01 comparing control or normal with control or VPA.hatakeyama et al
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of VPA as compared with normal culture. Therefore 
inhibitory effect of VPA on cell proliferation in the 
presence of fibronectin and collagen type I cultured 
with VPA may be depend on that interactions between 
mesenchymal cells and ECM increased sensitization 
of the cells to proliferation inhibition induced VPA.
Based on the current results of the effect of VPA 
on  mesenchymal  cell  proliferation  inhibition,  we 
assayed the effect of cell differentiation, especially 
of osteoblastic cell differentiation, in the absence or 
presence of ECMs. Our results showed that VPA pro-
moted osteoblastic cell differentiation in the presence 
of an extracellular matrix, the collagen-coated plate. 
This result indicates that the inhibitory effect of VPA 
on cell proliferation on the collagen-coated plate at 
lower concentrations compared with that on the non-
coated plastic plate would be dependent on the effect 
of VPA on osteoblastic cell differentiation from mes-
enchymal cells to mature osteoblasts in cooperation 
with collagen, which is well known as a promoter of 
osteoblastic cell differentiation.20 Because it has been 
reported that VPA promoted cell differentiation from 
preosteoblast to osteoblast, which indicated the effect 
of  VPA  on  cell  differentiation  in  committed  cells 
such  as  from  osteoblast  to  mature  osteoblast,5  our 
results suggested that VPA could promote sequential 
cell differentiation from uncommitted mesenchymal 
cells to mature osteoblasts in the presence of ECMs. 
  Interestingly, VPA increased the gene expression level 
of osteoblastic marker genes even on the non-coated 
plastic plate, in which VPA had no inhibitory effect 
on cell proliferation in low concentrations. Since we 
added  minimum  supplements  for  osteoblastic  cell 
differentiation  including  ascorbic  acid  and  dexam-
ethasone, which are widely used for basal induction 
of  osteoblastic  cell  differentiation  of  various  mes-
enchymal cells including C3H10T1/2,21–23 VPA may 
enhance osteoblast cell fate determination and pro-
mote cell differentiation in the presence of ECMs.
In summary, this study reported on the relationship 
of VPA and ECMs in mesenchymal cell proliferation 
and cell differentiation. Additionally, this study could 
reflect the effects of VPA in in vivo conditions, but fur-
ther research would be necessary to clarify the mech-
anism of cell proliferation in the co-presence of VPA 
and other ECMs to provide further insight into the 
effect of VPA in mesenchymal tissue development.
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